03 NOVEMBER 2017 VIVANTA BY TAJ PRESIDENT MUMBAI

Transcription

1 Impact Your Brand Perception Presents 03 NOVEMBER 2017 VIVANTA BY TAJ PRESIDENT MUMBAI Brought to you by

2 GOVERNMENT INITIATIVES OVERVIEW The Indian Pharmaceuticals market enlarged at a CAGR of per cent during with the market increasing from US$ 6 billion in 2005 to US$ 36.7 billion in 2016 and is expected to expand at a CAGR of per cent to US$ 55 billion by For the attaining these objectives, it is essential for the Indian Pharmaceutical Industry to become Globally competitive through World Class Manufacturing Competencies with Superiority and Cost Efficiency of Production Capacity. There is need to cultivate State-of-the-art Support Infrastructure both for Production and Research. The Indian Pharmaceuticals Market is the third largest in terms of volume and thirteenth largest in terms of value. The Market has seen the entry of many foreign players as well as rise of many domestic manufacturers. India is the largest provider of Generic Drugs Globally with the Indian Generics making up for 20% of Global Exports in terms of volume. Recently, amalgamation has become a significant trait of the Indian Pharmaceutical Market as the Industry is highly fragmented. India enjoys a focal position in the Global Pharmaceuticals Sector. The country also has a large pool of Scientists and Engineers who have the prospective to steer the industry ahead to an even elevated level. Currently over 80% of the Antiretroviral Drugs used Globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian Pharmaceutical Companies. The Government of India unveiled Pharma Vision 2020 designed to make India a Global Front-runner in holistic Drug Manufacturing. Approval time for new facilities has been condensed to enhance investments. Further, the Government has introduced mechanisms such as the Drug Price Control Order and the National Pharmaceutical Pricing Authority to deal with the concern of affordability and availability of Medicines. Shri Ananth Kumar, Union Minister of Chemicals and Petrochemicals, has declared setting up of Chemical Hubs across the country, Quick Environment Clearances in existing clusters, Robust Infrastructure, and establishment of a Central Institute of Chemical Engineering and Technology to achieve the vision. THE ECONOMIC TIMES Today Pharmaceutical Sciences have become an interdisciplinary field which brings together all branches of science for the incessant search of new life-saving and life-giving products. With the advances in technology, Pharmaceutical Sciences have seen a transformation. Genomics, Proteomics, Molecular Modelling and Computer based Drug Design have taken drug discovery to a multitude of success. The Economic Times Pharma Congress 2017 is presented with the desire to provide a platform to Researchers, Scientists, Academicians, Pharmaceutical Industries, Healthcare Professionals and the various stakeholders to learn, evolve, discuss, share and get the knack of current Innovations.

3 SCHEDULE 09:30-10:00 Registration & Networking 10:00-10:05 Welcome Address by ET Edge 10:05-10:10 Opening Address by Dr. Maruthi Viswanathan, Chief Executive Officer, RxPrism 10:10-10:25 Chief Guest Address: Pharma Vision 2020 : Deepak Sawant, Hon ble Minister for Public Health & Family Welfare, Government of Maharashtra 10:25-10:35 Keynote Address: Future of Pharma Ranjit Shahani, Vice Chairman & Managing Director, Novartis 10:35-11:35 Panel Discussion 1: Leader s Outlook: Demystifying the Future of Pharma & Life Sciences Ambati Venu, Managing Director, Abbott India Annaswamy Vaidheesh, Vice President, South Asia & Managing Director, GlaxoSmithKline Pharmaceuticals CT Renganathan, Managing Director, RPG Life Sciences Dilip G Shah, Secretary General, Indian Pharmaceutical Alliance Moderator: Dr. Milind Antani, Lead - Pharma & Healthcare Practice, Nishith Desai & Associates 11:35-11:50 Tea/Coffee & Networking 11:50-12:00 Role of Pharma in digital healthcare - Ashish Srivastav, Vice President, Janssen India 12:00-13:00 Panel Discussion 2: Moving Beyond Generics: Innovation in Pharma the next step Daara Patel, Secretary General, IDMA Jawed Zia, Country President, Novartis Kanchana TK, Director General, OPPI Manoj Saxena, Managing Director, Bayer Zydus Pharma Sanjiv Navangul, Managing Director, Janssen Moderator: Hitesh Sharma, Partner & National Leader - Life Science Practice, India, EY 13:00-14:00 Lunch & Networking Parallel Track on Pharma Marketing and Biosimilar s, Biopharma & Pharma Business Parallel Tracks Track 1 Track 2 Pharma Business Pharma Marketing 14:00-14:45 Panel Discussion: Biopharma & Biosimilar market in Panel Discussion: Going Digital: The new normal Abhishek Lagvankar, Marketing, Medical Nutrition, Danone India - The way forward Dr. Sakharam Garale, Head Medical Affairs & Public Health, Commercial Leadership, Mylan Laboratories Dr. Ambrish Kumar Srivastava Vice President Clinical Research & Regulatory, Alkem Ranjit Madan, Chief Executive Officer, Life Sciences Sector Skill Development Council Ravi Limaye, President - Marketing, Biocon Sanish Davis, Medical Director - Cardiovascular, Metabolism & Endocrine, Covance Moderator : Dr. Nilima Kshirsagar, National Chair Clinical Pharmacology, ICMR 14:45-15:00 Tea/Coffee & Networking 15:00-15:30 Manufacturing in India: Making it Globally Compliant Shantanu Mukherjee, Legal Head, Asia Pacific and Japan, Lupin Sudesh Shetty, Partner and Head, Forensics, Life Sciences, KPMG 15:30 Close of Conference Alap Gandhi, Head Medical Affairs, GlaxoSmithKline Pharmaceuticals Jitendra Misra, Vice President Chief Information Officer, Wanbury Rinkesh Shah, Digital Marketing Strategist, Cipla Sudhakar Gayakwad, Vice President, FCB Ulka Moderator : John Mathew, Head - Digital & Multi Channel Marketing, Glenmark Special Address: Patient or a healthcare consumer Rashmi Thosar, Chief Executive Office & Founder, Brandcare

4 WHY SHOULD YOU ATTEND? PARTNERS To get a broader scope bringing the whole communication value chain together and hear from Industry Experts and Thought Leaders. To get an opportunity to connect with the largest assemblage of the various Stakeholders of the Pharma Fraternity. Expand your knowledge of the latest Business Models, Strategies and Best-Practices prevalent in the Industry. Title Partner Impact Your Brand Perception Associate Partner Get a holistic outline of the current focus of Technology in Pharma. To discuss, deliberate and network with Industry Experts, Professionals and Practitioners. Healthcare Communication Partner Agency Partner WHO SHOULD ATTEND? CEO s, CTO s, CIO s, Presidents, Vice Presidents, Directors and Heads of: Association Partners Pharmaceutical Companies Pharmacovigilance Strategy Drug Safety/Risk Management Information and Clinical Data Management Clinical Research Research & Development Clinical Trials Medical Affairs Regulatory Affairs Compliance Quality control / Assurance/GCP Clinical Study Design Safety Surveillance Subject Recruitment E-Clinical Systems A Monthly Journal Devoted to Medicine, Surgery & Public Health Media Partners

5 Impact Your Brand Perception Presents Brought to you by For more info: M: E: